Table of Contents
Volume 6 | Issue 4
Publication Date: November 2006
Abstract
No Access
Pay-Per View
Full Text
Add to Cart
Editorial | ||
 256-257 |
2006 - The Year in Review Edward Chu |
|
Meeting Highlights | ||
258-260 |
Highlights from: Fifth International Colorectal Cancer Congress; Naples, FL; October 2006 Manisha Gupta, Edward Chu |
|
Mini Review | ||
261-264 |
Commentary on a Phase III Trial of Bevacizumab plus XELOX or FOLFOX4 for First-Line Treatment of Metastatic Colorectal Cancer: The NO16966 Trial Preeta Tyagi, Axel Grothey |
|
Comprehensive Reviews | ||
265-272 |
Novel Targets for Anticancer Treatment Development in Colorectal Cancer Teresa Macarulla, Francisco Javier Ramos, Jaume Capdevila, Cristina Saura, Josep Tabernero |
|
278-287 |
Xeloda® in Adjuvant Colon Cancer Therapy (X-ACT) Trial: Overview of Efficacy, Safety, and Cost-Effectiveness Chris J. Twelves on behalf of the X-ACT Investigators |
|
288-296 |
Profiling Dihydropyrimidine Dehydrogenase Deficiency in Patients with Cancer Undergoing 5-Fluorouracil/Capecitabine Therapy Cédric Mercier, Joseph Ciccolini |
|
Original Contributions | ||
297-304 |
Prognostic Factors Predictive of Response and Survival to a Modified FOLFOX Regimen: Importance of an Increased Neutrophil Count Michael Michael, David Goldstein, Stephen J. Clarke, Alvin D. Milner, Phillip Beale, Michael Friedlander, Paul Mitchell |
|
305-311 |
Gene Expression Levels of Epidermal Growth Factor Receptor, Survivin, and Vascular Endothelial Growth Factor as Molecular Markers of Lymph Node Involvement in Patients with Locally Advanced Rectal Cancer Dongyun Yang, Sylke Schneider, Mizutomo Azuma, Syma Iqbal, Anthony El-Khoueiry, Susan Groshen, Dana Agafitei, Kathleen D. Danenberg, Peter V. Danenberg, Robert D. Ladner, Heinz-Josef Lenz |
|
Clinical Trials | ||
312 |
Selected Clinical Trials in Colorectal Cancer CIG Media Group |
|
